Skip to content

Clinical trials

Choroidal Neovascularization trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Country / region: Switzerland Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20071
20102
20111
20133
20151
20191
20201
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Novartis3
Vista Klinik2
EyeBiotech Ltd.1
Ophthotech Corporation1
University Hospital, Basel, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization15
Macular Degeneration13
Vision Disorders4
Wet Macular Degeneration4
Geographic Atrophy3
Eye Diseases2
Retinal Degeneration2
Retinal Diseases2
Myopia, Degenerative1
Retinal Vein Occlusion1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.